π•Šπ•”π•šπ•–π•Ÿπ•₯π•šπ•€π•₯𝕀 𝕙𝕒𝕧𝕖 π•šπ••π•–π•Ÿπ•₯π•šπ•—π•šπ•–π•• 𝕒 π•Ÿπ•–π•¨ π•”π• π•£π• π•Ÿπ•’π•§π•šπ•£π•¦π•€ π•šπ•Ÿ 𝕓𝕒π•₯𝕀, 𝕓𝕦π•₯ π•šπ•₯’𝕀 π•Ÿπ• π•₯ 𝕒 π•‘π•¦π•“π•π•šπ•” 𝕙𝕖𝕒𝕝π•₯𝕙 π•₯𝕙𝕣𝕖𝕒π•₯

π•Šπ•”π•šπ•–π•Ÿπ•₯π•šπ•€π•₯𝕀 𝕙𝕒𝕧𝕖 π•šπ••π•–π•Ÿπ•₯π•šπ•—π•šπ•–π•• 𝕒 π•Ÿπ•–π•¨ π•”π• π•£π• π•Ÿπ•’π•§π•šπ•£π•¦π•€ π•šπ•Ÿ 𝕓𝕒π•₯𝕀, 𝕓𝕦π•₯ π•šπ•₯’𝕀 π•Ÿπ• π•₯ 𝕒 π•‘π•¦π•“π•π•šπ•” 𝕙𝕖𝕒𝕝π•₯𝕙 π•₯𝕙𝕣𝕖𝕒π•₯

Scientists at the Wuhan Institute of Virology in China have discovered a new lineage of a coronavirus in bats that can enter human cells in a similar fashion as SARS-CoV-2, the virus that causes Covid-19, according to a recently published study. But there are no reported infections in humans, and experts say it’s not currently a threat to public health.

Like SARS-CoV-2, HKU5-CoV-2 can enter cells via the human ACE2 receptor protein on cell surfaces. The newly identified coronavirus is a part of the same family as the virus that causes deadly Middle East respiratory syndrome, or MERS.

According to the study, published last week in theΒ journal Cell, scientists found the coronavirus in anal swab samples taken from a bat of the genus Pipistrellus. A lab experiment showed that the virus could infect human cells.

HKU5-CoV-2 can already infect human cells and is related to a virus with a 30% fatality rate. Now, researchers want to test it on humanized mice – because that worked out so well last time.

Dr. Alina Chan, a molecular biologist at the Broad Institute of MIT and Harvard, called the plans “ominous,” warning that WIV’s biosafety measures are a joke, yet, here they are, playing with fire again. What could possibly go wrong? This just needs to stop!

π•„π•’π•£π•šπ•  ℕ𝕒𝕨𝕗𝕒𝕝

Source

π•‹π•£π•¦π•žπ•‘ π•‹π•–π•’π•ž π•Žπ•–π•šπ•˜π•™π•€ β„™π•¦π•π•π•šπ•Ÿπ•˜ π”½π•¦π•Ÿπ••π•€ 𝕗𝕠𝕣 π•„π• π••π•–π•£π•Ÿπ•’ π”Ήπ•šπ•£π•• 𝔽𝕝𝕦 π•π•’π•”π•”π•šπ•Ÿπ•–

π•‹π•£π•¦π•žπ•‘ π•‹π•–π•’π•ž π•Žπ•–π•šπ•˜π•™π•€ β„™π•¦π•π•π•šπ•Ÿπ•˜ π”½π•¦π•Ÿπ••π•€ 𝕗𝕠𝕣 π•„π• π••π•–π•£π•Ÿπ•’ π”Ήπ•šπ•£π•• 𝔽𝕝𝕦 π•π•’π•”π•”π•šπ•Ÿπ•–

US health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded toΒ Moderna Inc., people familiar with the matter said.

The review is part of a government push to examine spending on messenger RNA-based vaccines, the technology that powered Moderna’s Covid vaccine. The bird flu shot contract was awarded to Moderna in the Biden administration’s final days, sending the company’s stock up 13% in the two days following the Jan. 17 announcement.

Shares of Moderna fell as much as 4.9% in trading before US markets openedThursday. The company didn’t respond to a request for comment.

The US is in the midst of a record-breaking bird flu outbreak that’s affectedΒ dozens of cattle herdsΒ along with poultry flocks nationwide, sendingΒ egg pricessoaring. While human cases have been relatively rare, the virus has caused deaths in the past, and experts are concerned that it could become more transmissible and dangerous.

𝔻𝕣 π•„π•’π•£π•˜π•’π•£π•–π•₯ π”Έπ•£π•’π•Ÿπ••π•’ π”½π•–π•£π•£π•’π•Ÿπ•₯𝕖

Source